<DOC>
	<DOCNO>NCT00875082</DOCNO>
	<brief_summary>Airway smooth muscle cell layer thicken sub epithelial fibrosis , key allergen-induced airway remodelling feature modulate corticosteroid , reversible CysLT1 receptor blockade therapy animal . No data available , present , potential effect LTs receptor antagonists airway remodelling asthmatic child . In present study , investigator aim ass whether addition montelukast ICS mild asthmatic child inhibit release MMP-9 , TIMP-1 , MMP-12 , MMP-9/TIMP1 ratio , procollagen type I C-terminal peptide ( PICP ) TGF-beta airway fluid collect induced sputum asthmatic child . 30-40 atopic child mild persistent asthma . Children asthma recruit evaluated real life open label trial : randomise two group first visit ( T1 ) : 1 ) group A : patient montelukast tablet 5 mg need beta agonist administer ; 2 ) group B : patient beta agonist therapy . All child evaluate 8 week ( T2 ) . They test lung function , FeNO , metalloproteinase ( MMP ) -9 , MMP-12 , tissue inhibitor metalloproteinase-1 ( TIMP-1 ) , procollagen type I C-terminal peptide ( PICP ) TGF-beta1 level sputum .</brief_summary>
	<brief_title>Effect Montelukast Remodelling Markers Asthmatic Children</brief_title>
	<detailed_description />
	<mesh_term>Montelukast</mesh_term>
	<criteria>Diagnostic criterion : classification asthma base clinical history examination pulmonary function parameter , accord international guideline . Stage and/or severity condition : atopic child mild intermittent asthma enrol . Atopy evaluate skinprick test common allergens area . Confirmatory physical laboratory finding : Age : ranging age 6 14 year . Evidence susceptibility disease study Patients use ICS 3month period prior study entry Patients exclude used oral steroid last month . Patients exclude acute chronic lung disease asthma , upper low airway infection previous 3 week trial , acute asthma exacerbation , use oral steroid last month . Patients exclude acute chronic lung disease asthma , upper low airway infection previous 3 week trial , acute asthma exacerbation , use oral steroid last month .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Children</keyword>
	<keyword>Remodelling</keyword>
	<keyword>Metalloproteinases</keyword>
	<keyword>Montelukast</keyword>
</DOC>